Real-time enrollment status for this lymphatic malformations clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 10:24 PM UTC
| NCT Number | NCT05948943 |
| Recruiting Status | Recruiting |
| Condition | Lymphatic Malformations |
| Phase | PHASE2 |
| Target Enrollment | 232 participants |
| Active Locations | 18 sites in the US |
| Sponsor | Novartis Pharmaceuticals |
| Last Updated on CT.gov | July 14, 2026 (3 days ago) |
As of July 17, 2026: Clinical trial NCT05948943 is currently recruiting participants. This phase2 study for lymphatic malformations is actively seeking new participants at 18 locations across the United States. The study is sponsored by Novartis Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05948943 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 18 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05948943 was last updated 3 days ago (July 14, 2026). HelloStudys verifies this status automatically.